Treatment review. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Treatment review. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Treat Review. 1995 Jan;(no 16):5. Unique Identifier : AIDSLINE AIDS/95700313

Abstract: HIV patients experiencing eye problems should see an ophthalmologist experienced in examining and treating people with HIV. Studies are showing that effective treatments do exist for eye problems associated with HIV infection. For example, one treatment, Adatomed Silicone Oil, has been approved by the Food and Drug Administration (FDA) for treating detached retinas, a symptom of CMV infection in the eyes. This treatment is available by prescription. An additional treatment option for CMV infection control in the eyes is oral ganciclovir. This route is used following successful catheter-delivered treatment of ganciclovir. The pill form, developed by Syntex, received FDA approval for marketing on January 5, 1995. The oral form of ganciclovir is attractive for two reasons: it is less risky than using a catheter, and it is easier to take despite the need for up to twelve pills daily. Doctors can call (800) 569-4630 for more information. A trial studying oral ganciclovir for treatment of CMV in children is now open.
Keywords: Administration, Oral AIDS-Related Opportunistic Infections/*DRUG THERAPY Cytomegalovirus Retinitis/COMPLICATIONS/*DRUG THERAPY Ganciclovir/ADMINISTRATION & DOSAGE/*THERAPEUTIC USE Human Retinal Detachment/COMPLICATIONS/*DRUG THERAPY Silicone Oils/*THERAPEUTIC USE NEWSLETTER ARTICLEKWDadministration,oralaids-relatedopportunisticinfections/KWDdrugtherapycytomegalovirusretinitis/complications/KWDdrugtherapyganciclovir/administration&dosage/KWDtherapeuticusehumanretinaldetachment/complications/KWDdrugtherapysiliconeoils/KWDtherapeuticusenewsletterarticle
950930
M9591260

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .